Acurx Pharmaceuticals Inc expected to post a loss of 24 cents a share - Earnings Preview

Acurx Pharmaceuticals

13/05/2024 14:16

* Acurx Pharmaceuticals Inc  ACXP.OQ   ACXP.O  is expected
to show
no change in quarterly revenue when it reports  results on May
15 for the period ending March 31 2024
    * 
    * ​LSEG's mean analyst estimate for Acurx Pharmaceuticals
Inc is
for a loss of 24 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Acurx
Pharmaceuticals Inc is $12.18​, above​ its last closing price
of $2.03. ​​​

This summary was machine generated May 13 at 13:16 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)